Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer to Distribute Nonlinear Dynamics Proteomics Software

NEW YORK, July 11 - PerkinElmer has agreed to non-exclusively distribute Nonlinear Dynamics' software for automating the analysis of proteins in 2D gel electrophoresis experiments, the companies said Wednesday.

PerkinElmer, based in Boston, has integrated the software platform, called Progenesis, into its ProXpress imaging system for analyzing proteins in 2D gel experiments, and will distribute the software worldwide. Financial details were not disclosed.

The agreement strengthens PerkinElmer's position in the $1.5 billion proteomics market, said John Engel, president of PerkinElmer Life Sciences, in a statement.

Nonlinear Dynamics, based in Newcastle, UK, has specialized in creating software for electrophoresis analysis over its ten years in existence. The company also has an agreement with Hitachi subsidiary MiraiBio to distribute earlier versions of Nonlinear Dynamics' software.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.